These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15941013)

  • 1. Occupational exposure limits in the context of solvent mixtures, consumption of ethanol, and target tissue dose.
    Dennison JE; Bigelow PL; Andersen ME
    Toxicol Ind Health; 2004 Sep; 20(6-10):165-75. PubMed ID: 15941013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of solvent central nervous system toxicity and ethanol interactions using a human population physiologically based kinetic and dynamic model.
    MacDonald AJ; Rostami-Hodjegan A; Tucker GT; Linkens DA
    Regul Toxicol Pharmacol; 2002 Apr; 35(2 Pt 1):165-76. PubMed ID: 12052002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational estimation of errors generated by lumping of physiologically-based pharmacokinetic (PBPK) interaction models of inhaled complex chemical mixtures.
    LeFew W; El-Masri H
    Inhal Toxicol; 2012 Jan; 24(1):36-46. PubMed ID: 22149415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A PBPK modeling-based approach to account for interactions in the health risk assessment of chemical mixtures.
    Haddad S; Béliveau M; Tardif R; Krishnan K
    Toxicol Sci; 2001 Sep; 63(1):125-31. PubMed ID: 11509752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of potential toxicity from co-exposure to three CNS depressants (toluene, ethylbenzene, and xylene) under resting and working conditions using PBPK modeling.
    Dennison JE; Bigelow PL; Mumtaz MM; Andersen ME; Dobrev ID; Yang RS
    J Occup Environ Hyg; 2005 Mar; 2(3):127-35. PubMed ID: 15764536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of physiologically based pharmacokinetic modelling to combination toxicology.
    Simmons JE
    Food Chem Toxicol; 1996; 34(11-12):1067-73. PubMed ID: 9119317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Derivation of internal dose-based thresholds of toxicological concern for occupational inhalation exposure to systemically acting organic chemicals.
    Chebekoue SF; Krishnan K
    J Occup Environ Hyg; 2019 Apr; 16(4):308-319. PubMed ID: 30676257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The application of physiologically based pharmacokinetic/pharmacodynamic (PBPK/PD) modeling for exploring risk assessment approaches of chemical mixtures.
    Yang RS; el-Masri HA; Thomas RS; Constan AA; Tessari JD
    Toxicol Lett; 1995 Sep; 79(1-3):193-200. PubMed ID: 7570656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical mixtures in the workplace. Research and practice.
    McCauley LA
    AAOHN J; 1998 Jan; 46(1):29-40; quiz 41-2. PubMed ID: 9481217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organic solvents and the dopaminergic system.
    Gralewicz S; Dyzma M
    Int J Occup Med Environ Health; 2005; 18(2):103-13. PubMed ID: 16201201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Difficulty of mode of action determination for trichloroethylene: An example of complex interactions of metabolites and other chemical exposures.
    Caldwell JC; Keshava N; Evans MV
    Environ Mol Mutagen; 2008 Mar; 49(2):142-54. PubMed ID: 17973308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of chemical mixture interactions modulating dermal absorption using a multiple membrane fiber array.
    Baynes RE; Xia XR; Imran M; Riviere JE
    Chem Res Toxicol; 2008 Mar; 21(3):591-9. PubMed ID: 18298091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological modeling and extrapolation of pharmacokinetic interactions from binary to more complex chemical mixtures.
    Krishnan K; Haddad S; Béliveau M; Tardif R
    Environ Health Perspect; 2002 Dec; 110 Suppl 6(Suppl 6):989-94. PubMed ID: 12634130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of two different metabolic hypotheses for dichloromethane toxicity using physiologically based pharmacokinetic modeling for in vivo inhalation gas uptake data exposure in female B6C3F1 mice.
    Evans MV; Caldwell JC
    Toxicol Appl Pharmacol; 2010 May; 244(3):280-90. PubMed ID: 20153349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental and mathematical modeling methods for the investigation of toxicological interactions.
    El-Masri HA
    Toxicol Appl Pharmacol; 2007 Sep; 223(2):148-54. PubMed ID: 16996550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicokinetics of organic solvents: a review of modifying factors.
    Löf A; Johanson G
    Crit Rev Toxicol; 1998 Nov; 28(6):571-650. PubMed ID: 9861527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosome aberrations in workers exposed to organic solvents: Influence of polymorphisms in xenobiotic-metabolism and DNA repair genes.
    Hoyos-Giraldo LS; Carvajal S; Cajas-Salazar N; Ruíz M; Sánchez-Gómez A
    Mutat Res; 2009 Jun; 666(1-2):8-15. PubMed ID: 19481674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and chronic effects of carrier solvents in aquatic organisms: a critical review.
    Hutchinson TH; Shillabeer N; Winter MJ; Pickford DB
    Aquat Toxicol; 2006 Jan; 76(1):69-92. PubMed ID: 16290221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity assessment of organic contaminants: evaluation of mixture effects in model industrial mixtures using 2n full factorial design.
    Parvez S; Venkataraman C; Mukherji S
    Chemosphere; 2008 Oct; 73(7):1049-55. PubMed ID: 18789476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating pharmacokinetic and pharmacodynamic interactions with computational models in supporting cumulative risk assessment.
    Tan YM; Clewell H; Campbell J; Andersen M
    Int J Environ Res Public Health; 2011 May; 8(5):1613-30. PubMed ID: 21655141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.